Business Description
Beijing Sunho Pharmaceutical Co Ltd
ISIN : CNE100005Z47
Share Class Description:
BJSE:430017: Ordinary SharesCompare
Compare
Traded in other countries / regions
430017.China IPO Date
2023-05-31Description
Beijing Sunho Pharmaceutical Co Ltd engages in the research and development, production, and sales of pharmaceutical preparations while providing CMC/CMO integrated services for pharmaceutical preparation manufacturers and innovative drug R&D enterprises. The company produces small-volume injections, freeze-dried powder injections, hard capsules, tablets, and other products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 56.11 | |||||
| Equity-to-Asset | 0.81 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.12 | |||||
| Interest Coverage | 389.82 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.65 | |||||
| Beneish M-Score | -2.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.4 | |||||
| 3-Year EBITDA Growth Rate | 2.1 | |||||
| 3-Year EPS without NRI Growth Rate | -2.5 | |||||
| 3-Year FCF Growth Rate | -21.4 | |||||
| 3-Year Book Growth Rate | -4.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.92 | |||||
| 9-Day RSI | 39.62 | |||||
| 14-Day RSI | 41.9 | |||||
| 6-1 Month Momentum % | 52.81 | |||||
| 12-1 Month Momentum % | 18.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.86 | |||||
| Quick Ratio | 3.57 | |||||
| Cash Ratio | 2.96 | |||||
| Days Inventory | 107.28 | |||||
| Days Sales Outstanding | 41.52 | |||||
| Days Payable | 124.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.69 | |||||
| Dividend Payout Ratio | 0.58 | |||||
| Forward Dividend Yield % | 1.69 | |||||
| 5-Year Yield-on-Cost % | 1.69 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 1.4 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.59 | |||||
| Operating Margin % | 13.51 | |||||
| Net Margin % | 13.9 | |||||
| FCF Margin % | 6.98 | |||||
| ROE % | 6.58 | |||||
| ROA % | 5.35 | |||||
| ROIC % | 8.44 | |||||
| ROC (Joel Greenblatt) % | 16.7 | |||||
| ROCE % | 6.91 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.85 | |||||
| PE Ratio without NRI | 19.15 | |||||
| Shiller PE Ratio | 18.22 | |||||
| Price-to-Owner-Earnings | 33.01 | |||||
| PEG Ratio | 1.43 | |||||
| PS Ratio | 2.58 | |||||
| PB Ratio | 1.2 | |||||
| Price-to-Tangible-Book | 1.22 | |||||
| Price-to-Free-Cash-Flow | 37.16 | |||||
| Price-to-Operating-Cash-Flow | 14.81 | |||||
| EV-to-EBIT | 10.15 | |||||
| EV-to-EBITDA | 10.15 | |||||
| EV-to-Revenue | 1.6 | |||||
| EV-to-FCF | 22.91 | |||||
| Price-to-Projected-FCF | 1.05 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.22 | |||||
| Price-to-Graham-Number | 1.01 | |||||
| Price-to-Net-Current-Asset-Value | 2.85 | |||||
| Price-to-Net-Cash | 4.51 | |||||
| Earnings Yield (Greenblatt) % | 9.85 | |||||
| FCF Yield % | 2.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Sunho Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 709.905 | ||
| EPS (TTM) (Â¥) | 0.79 | ||
| Beta | 0.05 | ||
| Volatility % | 43.2 | ||
| 14-Day RSI | 41.9 | ||
| 14-Day ATR (Â¥) | 1.268504 | ||
| 20-Day SMA (Â¥) | 16.187 | ||
| 12-1 Month Momentum % | 18.3 | ||
| 52-Week Range (Â¥) | 10.25 - 19.3 | ||
| Shares Outstanding (Mil) | 122.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Sunho Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Sunho Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Sunho Pharmaceutical Co Ltd Frequently Asked Questions
What is Beijing Sunho Pharmaceutical Co Ltd(BJSE:430017)'s stock price today?
The current price of BJSE:430017 is ¥14.47. The 52 week high of BJSE:430017 is ¥19.30 and 52 week low is ¥10.25.
When is next earnings date of Beijing Sunho Pharmaceutical Co Ltd(BJSE:430017)?
The next earnings date of Beijing Sunho Pharmaceutical Co Ltd(BJSE:430017) is .
Does Beijing Sunho Pharmaceutical Co Ltd(BJSE:430017) pay dividends? If so, how much?
The Dividend Yield %  of Beijing Sunho Pharmaceutical Co Ltd(BJSE:430017) is 1.69% (As of Today), Highest Dividend Payout Ratio of Beijing Sunho Pharmaceutical Co Ltd(BJSE:430017) was 0.58. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Beijing Sunho Pharmaceutical Co Ltd(BJSE:430017) is 1.69%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers